Mutations specified The point that, as discussed under, CLL therapy is based on the presence or absence of these mutations. The present consensus is usually that, besides clonal mutations, subclonal mutations with a variant allelic frequency starting from 5 to 10% (and as a consequence below the brink of detection https://bobbym530irz8.vblogetin.com/profile